VEGFA and neoplasm: However, VEGFA-121 overexpression can reduce tumor sensitivity to inhibitors of KDR receptor, particularly sorafenib, since VEGFA-121 mainly acts through alternative FLT-1 receptor (Rapisarda & Melillo, 2012; Vempati, Popel & Mac Gabhann, 2014).